Neoadjuvant Chemotherapy in Pregnant Patients with Cervical Cancer: A Monocentric Retrospective Study.

Federica BernardiniGabriella FerrandinaCaterina RicciAnna FagottiFrancesco FanfaniAnna Franca CavaliereBenedetta GuiGiovanni ScambiaRosa Pasqualina De Vincenzo

Published in: Current oncology (Toronto, Ont.) (2022)

NACT seems to be safe and efficacious in controlling tumor burden during pregnancy. CRH following NACT appears to be feasible, avoiding repeated surgery and treatment delays. This approach is also reasonably safe from a maternal, obstetric, and neonatal point of view.

Keyphrases

neoadjuvant chemotherapy
locally advanced
pregnant women
lymph node
minimally invasive
sentinel lymph node
coronary artery bypass
pregnancy outcomes
birth weight
rectal cancer
radiation therapy
combination therapy
atrial fibrillation
percutaneous coronary intervention
acute coronary syndrome
preterm birth